HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MABWELL-B

20.580

-0.020-0.10%

Volume:206.80K

Turnover:4.22M

Market Cap:9.20B

PE:-8.47

High:20.580

Open:21.000

Low:20.300

Close:20.600

52wk High:31.460

52wk Low:19.860

Shares:447.00M

HK Float Shares:47.13M

Volume Ratio:0.88

T/O Rate:0.44%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.430

ROE:-91.76%

ROA:-10.61%

PB:9.02

PE(LYR):-8.47

PS:9.01

Loading ...

Overview Company News Filings

Mabwell Reports Encouraging Mid-Stage Data for Anti-ST2 Antibody 9MW1911; Plans Phase III Launch by End-2026

Bulletin Express

Mabwell H1 2026: Revenue Soars 209% on Product Sales and Licensing; Net Loss Narrows

Bulletin Express

Mabwell-B climbs over 7% intraday as first-half revenue and gross profit surge sharply

Mabwell Schedules 17 September 2026 Extraordinary Meeting to Vote on SynuSight Agreements and Business Scope Amendment

Bulletin Express

MABWELL-B (02493) Posts Substantial Revenue and Gross Profit Growth in First Half, Core Pipeline Achieves Multiple Key Clinical Milestones

Mabwell Plans Broader Business Lines and Updates to Articles of Association Ahead of EGM

Bulletin Express

Mabwell Sets 30 August Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express

Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge

MABWELL-B Surges Over 13% in Morning Trade After Two Denosumab Injections Pass Brazilian Regulator GMP Inspection

Mabwell (688062.SH) Receives NMPA Approval for 9MW5211 Injection Clinical Trial Application

Mabwell Bio Gets China Clinical Trial Approval for Vitiligo Drug

MT Newswires Live

Mabwell secures NMPA clearance to begin clinical trials of 9MW5211 for vitiligo

Bulletin Express

Mabwell Bioscience Gets China Nod for Diabetes Mellitus Drug Candidate Trial

MT Newswires Live

Mabwell Receives Regulatory Clearance for Clinical Trial of 9MW5211 Injection Targeting Type 1 Diabetes

Mabwell Reports No Change in Share Capital or Share Count for June 2026; Public Float Fully Compliant

Bulletin Express

Mabwell gains NMPA approval for 9MW5211 multiple-sclerosis trial; IBD programme cleared in China and U.S.

Bulletin Express

Mabwell Gets China Nod for Hematological Malignancy Drug Trial

MT Newswires Live

Mabwell Bioscience Receives Regulatory Clearance to Initiate Human Trials for Investigational Drug 6MW5311

Key Developments for Hong Kong Stocks: New Policy to Boost AI in Consumption and Strait Closure

Mabwell Highlights Promising Survival and Response Data for Nectin-4 ADC 9MW2821 in Cervical Cancer at ESMO Gynae 2026

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/02493/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02493","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","market":"HK","secType":"STK","nameCN":"MABWELL-B","latestPrice":20.58,"timestamp":1789027722187,"preClose":20.6,"halted":0,"volume":206800,"delay":0,"changeRate":-0.0009708737864079187,"floatShares":47130200,"shares":447000000,"eps":-2.43,"marketStatus":"Not Yet Opened","change":-0.02,"latestTime":"09-10 16:08:42","open":21,"high":20.58,"low":20.3,"amount":4219292,"amplitude":0.013592,"askPrice":20.58,"askSize":200,"bidPrice":20.36,"bidSize":1800,"shortable":0,"etf":0,"ttmEps":-2.422,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1777305600000,"exchange":"SEHK","adjPreClose":20.6,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.875085,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688062","market":"SH","secType":"STK","nameCN":"Mabwell(Shanghai)Bioscience Co.,Ltd.","latestPrice":25.6,"timestamp":1789023600000,"preClose":26.02,"halted":0,"volume":5291800,"delay":0,"premium":"-31.17"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","floatShares":47130200,"roa":"-10.61%","roe":"-91.76%","lyrEps":-2.43,"volumeRatio":0.875085,"shares":447000000,"dividePrice":0,"high":20.58,"amplitude":0.013592,"preClose":20.6,"low":20.3,"week52Low":19.86,"pbRate":"9.02","psRate":"9.01","week52High":31.46,"institutionHeld":0,"latestPrice":20.58,"committee":0.8,"eps":-2.43,"divideRate":0,"volume":206800,"delay":0,"ttmEps":-2.422,"open":21,"prevYearClose":27.64,"prevWeekClose":20.76,"prevMonthClose":20.7,"prevQuarterClose":23.32,"fiveDayClose":20.84,"twentyDayClose":23.3,"sixtyDayClose":25.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02493\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-08-31","symbol":"02493","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1788105600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02493\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02493\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1783699200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02493\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02493","date":"2026-09-09","current":-8.49711,"percent":1,"low":-17.302507,"twenty":-15.659552,"median":-14.431979,"eighty":-12.99766,"high":-11.915593,"avg":-14.409238,"sd":1.378269,"marketCap":13085627584.26},"quantilePoints":[{"date":"2026-04-24","current":-15.289641,"twenty":-16.199622,"median":-15.659552,"eighty":-15.437605,"marketCap":17000217748.15},{"date":"2026-04-30","current":-16.640195,"twenty":-16.379645,"median":-15.593679,"eighty":-15.250239,"marketCap":17562577595.07},{"date":"2026-05-08","current":-16.416983,"twenty":-16.631559,"median":-16.471868,"eighty":-15.350449,"marketCap":17380742435.69},{"date":"2026-05-15","current":-16.009725,"twenty":-16.685787,"median":-16.416983,"eighty":-15.606854,"marketCap":16994157190.87},{"date":"2026-05-22","current":-15.517615,"twenty":-16.631559,"median":-16.0746,"eighty":-15.529829,"marketCap":16434142933.1},{"date":"2026-05-29","current":-14.179755,"twenty":-16.597014,"median":-15.628209,"eighty":-15.240388,"marketCap":15069483633.31},{"date":"2026-06-05","current":-12.517432,"twenty":-16.559668,"median":-15.581594,"eighty":-14.26556,"marketCap":13322161865.15},{"date":"2026-06-12","current":-13.472006,"twenty":-16.526753,"median":-15.469041,"eighty":-13.356302,"marketCap":14328406594.37},{"date":"2026-06-18","current":-12.99766,"twenty":-16.438937,"median":-15.265014,"eighty":-12.92448,"marketCap":13857073336},{"date":"2026-06-26","current":-12.199681,"twenty":-16.378066,"median":-14.95714,"eighty":-12.901569,"marketCap":12942815528.08},{"date":"2026-07-03","current":-14.979824,"twenty":-16.23102,"median":-14.955208,"eighty":-12.918972,"marketCap":15904197681.19},{"date":"2026-07-10","current":-14.849801,"twenty":-16.061625,"median":-14.902504,"eighty":-12.970767,"marketCap":15746801597.92},{"date":"2026-07-17","current":-14.420221,"twenty":-16.08484,"median":-14.955208,"eighty":-13.013901,"marketCap":15345691723.29},{"date":"2026-07-24","current":-14.443737,"twenty":-16.025201,"median":-14.968482,"eighty":-13.071825,"marketCap":15374169818.76},{"date":"2026-07-31","current":-13.354051,"twenty":-15.926439,"median":-14.902504,"eighty":-13.105062,"marketCap":14241292067.7},{"date":"2026-08-07","current":-14.221458,"twenty":-15.744727,"median":-14.562278,"eighty":-13.056126,"marketCap":15195777985.44},{"date":"2026-08-14","current":-15.770582,"twenty":-15.789139,"median":-14.806347,"eighty":-13.105062,"marketCap":16872365889.11},{"date":"2026-08-21","current":-14.469039,"twenty":-15.760286,"median":-14.849801,"eighty":-13.131915,"marketCap":15514103639.81},{"date":"2026-08-28","current":-13.731399,"twenty":-15.716499,"median":-14.541981,"eighty":-13.197968,"marketCap":14726523718},{"date":"2026-09-04","current":-12.516523,"twenty":-15.668212,"median":-14.452874,"eighty":-13.105062,"marketCap":13723599618.54},{"date":"2026-09-09","current":-11.915593,"twenty":-15.659552,"median":-14.431979,"eighty":-12.99766,"marketCap":13085627584.26}],"updateTime":1789035607847},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02493\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155283328","title":"Mabwell Reports Encouraging Mid-Stage Data for Anti-ST2 Antibody 9MW1911; Plans Phase III Launch by End-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1155283328","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155283328?lang=en_us&edition=fundamental","pubTime":"2026-09-04 23:03","pubTimestamp":1788534238,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. has released a voluntary announcement detailing updated Phase Ib/IIa results for its investigational monoclonal antibody 9MW1911 in former smokers with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139625778","title":"Mabwell H1 2026: Revenue Soars 209% on Product Sales and Licensing; Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=1139625778","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139625778?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:22","pubTimestamp":1788528132,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (Mabwell-B; 02493) reported interim results for the six months ended 30 June 2026. Financial Highlights   • Revenue jumped 209.1% year-on-year to RMB 312.45...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Mabwell H1 2026: Revenue Soars 209% on Product Sales and Licensing; Net Loss Narrows","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124793944","title":"Mabwell-B climbs over 7% intraday as first-half revenue and gross profit surge sharply","url":"https://stock-news.laohu8.com/highlight/detail?id=1124793944","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124793944?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:40","pubTimestamp":1788320429,"startTime":"0","endTime":"0","summary":"Shares of Mabwell-B (02493) surged more than 7% during intraday trading before paring gains, last up 1.56% at HK$20.84 with turnover of HK$6.99 million. The company recently released its 2026 interim...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183117377","title":"Mabwell Schedules 17 September 2026 Extraordinary Meeting to Vote on SynuSight Agreements and Business Scope Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=1183117377","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183117377?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:03","pubTimestamp":1788087785,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. has issued a proxy circular convening its 2026 fourth Extraordinary General Meeting (EGM), to be held on 17 September 2026 at 15:00 (Hong Kong time) in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103184789","title":"MABWELL-B (02493) Posts Substantial Revenue and Gross Profit Growth in First Half, Core Pipeline Achieves Multiple Key Clinical Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1103184789","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103184789?lang=en_us&edition=fundamental","pubTime":"2026-08-30 18:34","pubTimestamp":1788086056,"startTime":"0","endTime":"0","summary":"MABWELL-B (02493) has announced its interim results for 2026, reporting revenue of approximately RMB 312 million, a year-on-year surge of 209.06%. Gross profit reached roughly RMB 236 million, up...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156828438","title":"Mabwell Plans Broader Business Lines and Updates to Articles of Association Ahead of EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1156828438","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156828438?lang=en_us&edition=fundamental","pubTime":"2026-08-30 18:21","pubTimestamp":1788085300,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (Mabwell, HKEX: 02493) reported that its Board of Directors approved resolutions on 30 August 2026 to widen the company’s business scope and revise...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102496504","title":"Mabwell Sets 30 August Board Meeting to Approve 1H 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1102496504","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102496504?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:47","pubTimestamp":1787129263,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. has scheduled a board meeting for Sunday, 30 August 2026. The agenda includes deliberation and approval of the Group’s interim financial results for the six...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143946715","title":"Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1143946715","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143946715?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:14","pubTimestamp":1786421692,"startTime":"0","endTime":"0","summary":"The benchmark Hang Seng Index fell 0.63%, dropping 163 points to 25,773 points, while the Hang Seng Tech Index declined 1.27%. Early session turnover on the Hong Kong exchange reached 115.8 billion...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07500","LU0228659784.USD","LU1064131342.USD","LU2097828631.EUR","LU0211977185.USD","LU0463099449.HKD","HHImain","LU0828238088.HKD","HK0000306701.USD","03067","LU1831875114.USD","LU0531971595.HKD","LU0417516902.SGD","BK1576","SG9999003461.SGD","LU0181495838.USD","LU1769817179.HKD","LU3063872942.SGD","03033","LU1188198961.HKD","LU0039217434.USD","09688","LU0164939612.USD","LU0106959298.USD","LU1224709979.USD","LU1769817096.USD","01548","LU0266512127.USD","LU1961090484.USD","LU1988902786.USD","LU0173614495.USD","BK1587","02026","LU0082770016.SGD","LU2008162690.USD","BK1190","LU1808992512.USD","LU2097828557.USD","03419","BK1183","BK1161","HSImain","LU0048580855.USD","688062","LU1048596156.SGD","LU1794554557.SGD","BK1592","LU1303224171.USD","LU2226246903.HKD","03423","03032","07226","LU0149721374.USD","LU0043850808.USD","07300","HSTECH","LU0287142896.SGD","LU0348825331.USD","LU0348827113.USD","LU0266512473.USD","LU0164880469.USD","ZIJMY","688234","ZLAB","HK0000320264.USD","BK1574","LU0572944931.SGD","03088","09088","02833","LU0797268264.HKD","BK1594","LU0348814723.USD","LU2399975544.HKD","LU0828237940.HKD","LU0106252389.USD","LU2488822045.USD","LU0326950275.SGD","02493","82800","PONY","02899","LU0348767384.USD","LU0370786039.SGD","LU1105468828.SGD","LU0634319403.HKD","LU0307460666.USD","LU0588546209.SGD","LU1770034418.SGD","02631","300408","LU1251922891.USD","LU0329678170.USD","LU0918141887.USD","LU0061477393.USD","09067","LU0348816934.USD","LU2097828805.USD","09115","LU0417516738.SGD","SG9999002463.SGD","LU0096374516.USD","LU1720050803.USD","LU1282648689.USD","03037","LU0329678337.USD","BK1141","LU0737861699.HKD","LU0561508036.HKD","300759","LU1481107354.HKD","LU0620787316.HKD","06951","LU0327786744.USD","LU0082770016.USD","LU0049853897.USD","LU0278937759.USD","LU0979878070.USD","HK0000306685.HKD","03417","HK0000320223.HKD","JINFF","LU0140636845.USD","BK1505","LU0348735423.USD","LU2039709279.SGD","002821","601899","LU0886674414.USD","LU0274383008.USD","MCHmain","01651","BK1198","02800","LU2097828714.EUR","83115","LU0456854461.SGD","SG9999004220.SGD","LU2097828474.EUR","LU1242518931.SGD","LU0328353924.USD","BK1583","LU0345780521.USD","LU0164865239.USD","LU0918141705.HKD","BK1544","03115","LU0540923850.HKD","LU2177674079.SGD","BK1109","LU0348766576.USD","02099","01541","HTImain","LU0737861772.HKD","LU0828237510.HKD","LU1242518857.USD","LU1719994722.HKD","03759","HSI","LU0269904917.USD","BK1588","LU0431992006.USD","LU0509642566.USD","IE0032431581.USD","07552","06821","LU2264538146.SGD","07200","LU0345780281.USD","SG9999001093.SGD","513600","LU0244354667.USD","BK1191","LU0868486357.SGD","LU1504937902.USD","BK1170","BK1169","LU0469268626.HKD","LU0821914370.USD","LU0871576103.HKD","BK1129","06616","LU0165289439.USD","02837","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197905914","title":"MABWELL-B Surges Over 13% in Morning Trade After Two Denosumab Injections Pass Brazilian Regulator GMP Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1197905914","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197905914?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:00","pubTimestamp":1786420827,"startTime":"0","endTime":"0","summary":"MABWELL-B (02493) surged over 13% during morning trading, with shares up 11.38% to HK$25.06 as of press time, on a turnover of HK$33.0181 million.According to an official announcement from MABWELL,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159100","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139319370","title":"Mabwell (688062.SH) Receives NMPA Approval for 9MW5211 Injection Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1139319370","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139319370?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:10","pubTimestamp":1785492637,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) has announced that it has received a \"Drug Clinical Trial Approval Notice\" from the National Medical Products Administration (NMPA). The approval...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK0239","02493","688062","BMED","IBBQ","IBBJ","BK1161","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651419002","title":"Mabwell Bio Gets China Clinical Trial Approval for Vitiligo Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419002","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651419002?lang=en_us&edition=fundamental","pubTime":"2026-07-16 14:55","pubTimestamp":1784184942,"startTime":"0","endTime":"0","summary":"Mabwell  Bioscience's  clinical trial application for 9MW5211 as treatment of vitiligo has been approved by China's National Medical Products Administration.The approval allows the company to proceed with clinical trials of 9MW5211 for the indication, according to a Wednesday Hong Kong bourse filing.Shares of the company rose nearly 1% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GDOC","HYLG","BK0239","IDNA","BK1161","02493","688062","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121072596","title":"Mabwell secures NMPA clearance to begin clinical trials of 9MW5211 for vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=1121072596","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121072596?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:41","pubTimestamp":1784119283,"startTime":"0","endTime":"0","summary":"On 15 July 2026, Mabwell (Shanghai) Bioscience Co., Ltd. disclosed that China’s National Medical Products Administration (NMPA) has approved the company’s clinical-trial application for 9MW5211...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649553963","title":"Mabwell Bioscience Gets China Nod for Diabetes Mellitus Drug Candidate Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649553963","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649553963?lang=en_us&edition=fundamental","pubTime":"2026-07-08 14:44","pubTimestamp":1783493094,"startTime":"0","endTime":"0","summary":"Mabwell  Bioscience  obtained clinical trial approval for 9MW5211 injection from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.Shanghai-listed shares of the drug company saw a nearly 3% decrease by Wednesday afternoon, with Hong Kong shares falling 4%.The drug will be tested for the treatment of Type 1 diabetes mellitus.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02493","688062","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199596221","title":"Mabwell Receives Regulatory Clearance for Clinical Trial of 9MW5211 Injection Targeting Type 1 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1199596221","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199596221?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:19","pubTimestamp":1783426792,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (ASX: 688062) has announced that it has received a clinical trial approval notice from the National Medical Products Administration.The approval pertains to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688062","BK1161","BMED","BK0239","IBBQ","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157380138","title":"Mabwell Reports No Change in Share Capital or Share Count for June 2026; Public Float Fully Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1157380138","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157380138?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:03","pubTimestamp":1783415001,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (Mabwell-B) filed its Monthly Return for Equity Issuers for the period ended 30 June 2026, confirming stable capital structure and full compliance with Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127398069","title":"Mabwell gains NMPA approval for 9MW5211 multiple-sclerosis trial; IBD programme cleared in China and U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=1127398069","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127398069?lang=en_us&edition=fundamental","pubTime":"2026-06-24 22:06","pubTimestamp":1782309965,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. announced that China’s National Medical Products Administration (NMPA) has approved a clinical-trial application for its innovative antibody 9MW5211 Injection...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645898242","title":"Mabwell Gets China Nod for Hematological Malignancy Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2645898242","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645898242?lang=en_us&edition=fundamental","pubTime":"2026-06-24 15:57","pubTimestamp":1782287873,"startTime":"0","endTime":"0","summary":"Mabwell  Bioscience  obtained approval for a clinical trial of 6MW5311 for Injection from China's National Medical Products Administration, according to a Wednesday Hong Kong bourse filing.The trial will test the drug for indications of hematological malignancies, including acute myeloid leukemia, chronic myelomonocytic leukemia, and multiple myeloma.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK0239","688062","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178147278","title":"Mabwell Bioscience Receives Regulatory Clearance to Initiate Human Trials for Investigational Drug 6MW5311","url":"https://stock-news.laohu8.com/highlight/detail?id=1178147278","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178147278?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:40","pubTimestamp":1782211223,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. has announced that it has received a clinical trial approval notice from the National Medical Products Administration.The approval pertains to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493","688062","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168120864","title":"Key Developments for Hong Kong Stocks: New Policy to Boost AI in Consumption and Strait Closure","url":"https://stock-news.laohu8.com/highlight/detail?id=1168120864","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168120864?lang=en_us&edition=fundamental","pubTime":"2026-06-22 07:32","pubTimestamp":1782084728,"startTime":"0","endTime":"0","summary":"Eight Chinese government departments have jointly issued an implementation plan to accelerate the integration of artificial intelligence with consumption. On the 18th, the Ministry of Commerce and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1048596156.SGD","LU0348805143.USD","LU0594300179.USD","LU0051755006.USD","LU0943347566.SGD","IE00B1XK9C88.USD","LU0244354667.USD","SG9999002828.SGD","IE00B3M56506.USD","LU1044875133.USD","LU2257852520.SGD","LU0348735423.USD","LU1956131251.USD","TEST","IE0003895053.USD","LU0293314216.USD","LU2476274720.SGD","LU1642822792.SGD","LU1366192091.USD","BK1255","TSLG","LU0315178854.USD","SG9999009443.AUD","LU1066051498.USD","LU2213496289.HKD","LU1568876251.USD","TSLP","LU1720051108.HKD","LU1770034418.SGD","LU0531971595.HKD","LU0211977185.USD","TSLL","LU0449515922.USD","LU1328277881.USD","LU0593848301.USD","LU2168563687.JPY","LU0067412154.USD","LU2087589342.USD","LU2226246903.HKD","01288","LU2357305700.SGD","IE0034224299.USD","LU1145028129.USD","LU1152091168.USD","LU1961090484.USD","LU2097828557.USD","LU1634259557.SGD","LU0287142896.SGD","TSLI","BK1502","LU0254981946.USD","LU2462157665.USD","LU1497733557.USD","LU0880133367.SGD","LU0441854154.USD","LU0607220059.USD","LU0345770993.USD","LU1674673428.USD","BK4604","IE00BQJZWZ67.USD","LU0234570918.USD","LU1880383440.USD","LU0052750758.USD","LU1504937902.USD","LU0823041008.USD","LU1267930730.SGD","SG9999015945.SGD","LU1323998911.USD","LU0228367735.SGD","LU0719512351.SGD","IE00B5MMRT66.SGD","LU0466842654.USD","LU1282651121.HKD","SG9999002562.SGD","00939","LU2750360997.AUD","LU1794554557.SGD","BK4534","LU0173614495.USD","LU0708995401.HKD","LU1066053197.SGD","LU0109391861.USD","LU0588545904.SGD","601328","LU1497734951.SGD","LU0348827113.USD","LU0348723411.USD","LU0499858438.USD","LU0819121731.USD","LU2097828805.USD","IE00B0JY6N72.USD","LU0264606111.USD","02513","LU0133085943.USD","LU0370786039.SGD","IE0032431581.USD","SG9999015986.USD","LU0572944931.SGD","LU2168564149.EUR","LU1051768304.USD","IE00BK4W5M84.HKD","LU1303224171.USD","IE00BPRC5H50.USD","LU1551013342.USD","LU2471134796.USD","IE00BK4W5L77.USD","LU0633140560.USD","LU0320765059.SGD","300750","LU2087621335.USD","LU0823397103.USD","LU0348825331.USD","LU1960683339.HKD","CRSH","IE00B19Z8W00.USD","LU0964807845.USD","LU0791591158.USD","BK1124","LU0056508442.USD","IE00B19Z8X17.USD","LU0164872284.USD","LU1044874839.SGD","LU2023250330.USD","LU1548497426.USD","BK4585","LU0820562030.AUD","01140","SG9999001069.SGD","LU2360106780.USD","01164","LU0359201612.USD","LU2213484517.USD","BK4548","LU0762540952.USD","LU1044876610.USD","LU0084288322.USD","LU1282651048.USD","LU1366334651.USD","LU0348814723.USD","LU1719994722.HKD","LU2778985437.USD","LU1839511570.USD","BK1524","BK1575","LU1023057109.AUD","LU0868486357.SGD","LU0611395673.USD","LU0820561818.USD","LU2896262040.SGD","LU0345769631.USD","LU0856984785.SGD","LU2097828631.EUR","BK1161","LU0572940350.SGD","BK1116","LU0820561909.HKD","SG9999001093.SGD","601939","BK4555","LU2417539215.USD","SGXZ90724238.SGD","LU0819123356.HKD","LU2399975544.HKD","HK0000286598.CNH","LU0708995583.HKD","LU2456880835.USD","LU2168564065.EUR","LU0345776255.USD","LU0054450605.USD","LU1551013425.SGD","BCMXY","LU2602419157.SGD","LU0164880469.USD","IE00BMCWC346.EUR","HK0000306701.USD","BK1523","LU0417516738.SGD","SG9999004220.SGD","HK0000306685.HKD","LU2449936058.SGD","LU2236285917.USD","BK1589","LU0823040885.USD","IE00BGHQDM52.EUR","LU2471134952.CNY","LU0831093199.SGD","01398","LU1568876335.HKD","LU0143863198.USD","LU1861559042.SGD","IDCBY","LU0463099449.HKD","LU1242518857.USD","BK4588","LU0047713382.USD","LU2097828474.EUR","LU1188198961.HKD","LU1852331112.SGD","TSLZ","BK1607","LU1981816686.USD","LU0456846285.SGD","XIACY","LU2326559502.SGD","LU0823039010.USD","CICHY","TSII","TSLS","BK1560","LU1066051225.USD","IE00BYV24P56.USD","IE00BVYPNP33.GBP","BK1220","601288","LU0320764599.SGD","LU2249611893.SGD","IE00B543WZ88.USD","IE00BJLML261.HKD","LU2168564222.USD","LU0737861699.HKD","LU0633140727.USD","LU0053666078.USD","SG9999007991.SGD","LU0259732245.USD","LU0163747925.USD","LU0345775950.USD","LU0651947912.USD","BACHY","LU1629891620.HKD","LU0823413587.USD","LU0918141705.HKD","LU1211504680.USD","LU0979878070.USD","LU1481107354.HKD","01392","LU0210526637.USD","BK4543","BK1178","LU1048588211.SGD","LU2360107168.USD","TSLQ","LU0323591593.USD","IE00B19Z5X02.USD","LU0630378429.USD","LU0315179316.USD","LU0316494557.USD","HK0000165453.HKD","601988","LU0043850808.USD","LU1515016050.SGD","LU0871576103.HKD","LU0588545490.SGD","BK4612","LU2420271590.USD","LU1674673691.USD","BK1592","LU0164865239.USD","BK4516","SG9999002463.SGD","LU0149534421.HKD","LU0561508036.HKD","LU2152927971.USD","LU0516423091.SGD","HK0000288784.HKD","LU2471134523.USD","LU0143863784.USD","LU1880383366.USD","LU0588545730.USD","TSLO","LU0235996351.USD","LU0650527681.SGD","LU0675040207.SGD","LU2750360641.GBP","BK4511","LU1008478684.HKD","LU0198837287.USD","688062","TSLY","LU2063271972.USD","LU2168564495.EUR","LU0396098781.USD","LU0165289439.USD","LU1778281490.HKD","LU0700851271.USD","LU0326950275.SGD","TSLR","03750","LU0791590937.USD","BK1521","LU2476274308.USD","BK4527","LU0797268264.HKD","SG9999015952.SGD","BK4551","LU0823038988.USD","03143","IE00BSNM7G36.USD","BK4592","HK0001040143.USD","BK1117","LU1105468828.SGD","LU0588546209.SGD","LU1224709979.USD","HK0000288743.USD","BK1610","LU0531970944.HKD","LU0039217434.USD","BK1615","HK0001040168.HKD","LU0096374516.USD","ACGBY","01810","HK0000320264.USD","LU0169518387.USD","LU0359202008.SGD","LU0516423174.USD","LU0865486749.SGD","LU2756315664.SGD","LU0072462343.USD","LU0307460666.USD","BK4533","BK4099","MIUmain","BK1231","LU1831875114.USD","07766","LU0082616367.USD","TESL","LU1914381329.SGD","LU2290526834.HKD","LU1242518931.SGD","BK1193","LU0327786744.USD","LU1813983027.USD","LU1051769294.HKD","LU0431992006.USD","00417","LU0348816934.USD","LU0149721374.USD","IE00BWDBJ730.SGD","LU0823411888.USD","LU0823397285.USD","BK4581","TSYY","LU0886674414.USD","BK1227","LU1861215975.USD","LU0516422440.USD","LU1224444064.USD","LU1282648689.USD","LU0821914370.USD","LU0456827905.SGD","601398","LU1861558580.USD","02493","HK0000914686.HKD","LU0210536198.USD","HK0000320223.HKD","TLA","TSDD","LU0345770308.USD","BK4574","LU1807302812.USD","LU0823426480.USD","LU1993786604.SGD","LU0594300419.USD","LU2250418816.HKD","LU2097828714.EUR","TSLA","LU0516422952.EUR","LU1868837565.USD","IE00B1BXHZ80.USD","SG9999001226.SGD","IE00B19Z9505.USD","LU0499858602.USD","LU0117841782.USD","LU1429558221.USD","LU0231483743.USD","LU1048484197.HKD","LU1522347837.USD","09766","SG9999015978.USD","BK1618","LU0061477393.USD","SG9999006597.SGD","LU1152091754.HKD","LU0097036916.USD","HK0000914660.USD","BK1545","BK4550","03328","81810","00306","LU2471134879.HKD","IE0034235303.USD","LU0572939691.SGD","IE00BVYPNQ40.USD","LU0417516902.SGD","LU0683595622.HKD","LU2294711473.HKD","LU0918141887.USD","LU2108987350.USD","LU0345769128.USD","LU1366334578.USD","LU0449509016.USD","LU2039709279.SGD","LU0823413660.USD","BK4598","LU0823426308.USD","HXXD.SI","HK0000107257.USD","LU0634319403.HKD","LU0140636845.USD","LU1066051811.HKD","LU1497733631.SGD","LU1861220033.SGD","07366","LU0516422366.SGD","SG9999014674.SGD","IE00BWXC8680.SGD","LU1232071149.USD","LU0048580855.USD","LU1435385759.SGD","LU0651946864.USD","LU0672654240.SGD","SG9999003461.SGD","LU0823414478.USD","LU0605514214.HKD","03988","09366","TSLT","LU2756315318.SGD","02302","LU1720050803.USD","LU1720051017.SGD","LU1808992512.USD","BK1156","LU0689472784.USD","TSL","LU0359201885.HKD","LU0469268626.HKD","SG9999001051.SGD","LU1770036033.HKD","BK1594","MIUmain","LU1251922891.USD","LU1868838027.USD","TSLW","SG9999013353.USD","LU2148611432.USD","LU0540923850.HKD","LU2403377893.USD","BK1506","LU0234572021.USD","LU0077335932.USD","LU1634259391.SGD","LU0314109678.HKD","LU0214875030.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161589357","title":"Mabwell Highlights Promising Survival and Response Data for Nectin-4 ADC 9MW2821 in Cervical Cancer at ESMO Gynae 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1161589357","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161589357?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:25","pubTimestamp":1781792742,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (Mabwell; stock name: MABWELL-B) released updated clinical results for its Nectin-4-targeting antibody-drug conjugate 9MW2821 (Bulumtatug Fuvedotin, BFv) ahead...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}]}}